Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285)

Market Cap	11.82B
Revenue (ttm)	3.56B
Net Income (ttm)	675.80M
Shares Out	563.16M
EPS (ttm)	1.20
PE Ratio	17.44
Forward PE	17.07
Dividend	0.80 (3.72%)
Ex-Dividend Date	n/a

Volume	5,951,601
Open	21.39
Previous Close	21.51
Day's Range	21.01 - 21.72
52-Week Range	16.15 - 27.26
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 26, 2025

About Henan Lingrui Pharmaceutical

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 2,530
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600285

Financial Performance

In 2023, Henan Lingrui Pharmaceutical's revenue was 3.31 billion, an increase of 10.31% compared to the previous year's 3.00 billion. Earnings were 568.11 million, an increase of 22.09%.